Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Verneris

Showing results (81-90 of 201) with videos related to

Pageof 21
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|April 25, 2013
Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cellsDaniel A Vallera, Bin Zhang, Michelle K Gleason, et al.
Blood Advances|August 30, 2021
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioningJohn E Wagner, Karen K Ballen, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methodsSteven A Dezell, Yong-Oon Ahn, Jan Spanholtz, et al.
American Journal of Hematology|July 8, 2015
Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failureTroy C Lund, Jessica Liegel, Nelli Bejanyan, et al.
Blood|May 15, 2007
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulationsHongbo Wang, Bartosz Grzywacz, David Sukovich, et al.
Stem Cells Translational Medicine|March 29, 2022
SAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic EndotheliumSeon-Hui Shim, Dejene Tufa, Renee Woods, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2010
Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignanciesMichael J Burke, Rachel Isaksson Vogel, Sanyukta K Janardan, et al.
Blood Advances|December 1, 2017
Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 ResponseRachel J Bergerson, Robin Williams, Hongbo Wang, et al.
American Journal of Hematology|June 4, 2014
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemiaMichael J Burke, Jatinder K Lamba, Stanley Pounds, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2012
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survivalVeronika Bachanova, Michael J Burke, Sophia Yohe, et al.
Pageof 21

Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
Cancer Biotherapy & Radiopharmaceuticals|April 25, 2013
Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cellsDaniel A Vallera, Bin Zhang, Michelle K Gleason, et al.
Blood Advances|August 30, 2021
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioningJohn E Wagner, Karen K Ballen, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methodsSteven A Dezell, Yong-Oon Ahn, Jan Spanholtz, et al.
American Journal of Hematology|July 8, 2015
Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failureTroy C Lund, Jessica Liegel, Nelli Bejanyan, et al.
Blood|May 15, 2007
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulationsHongbo Wang, Bartosz Grzywacz, David Sukovich, et al.
Stem Cells Translational Medicine|March 29, 2022
SAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic EndotheliumSeon-Hui Shim, Dejene Tufa, Renee Woods, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2010
Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignanciesMichael J Burke, Rachel Isaksson Vogel, Sanyukta K Janardan, et al.
Blood Advances|December 1, 2017
Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 ResponseRachel J Bergerson, Robin Williams, Hongbo Wang, et al.
American Journal of Hematology|June 4, 2014
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemiaMichael J Burke, Jatinder K Lamba, Stanley Pounds, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2012
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survivalVeronika Bachanova, Michael J Burke, Sophia Yohe, et al.
Pageof 21